Edition:
United States

Profile: Eli Lilly and Co (LLY)

LLY on New York Consolidated

81.75USD
19 Sep 2017
Change (% chg)

$-0.77 (-0.93%)
Prev Close
$82.52
Open
$82.64
Day's High
$82.84
Day's Low
$81.55
Volume
880,968
Avg. Vol
3,607,989
52-wk High
$86.72
52-wk Low
$64.18

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2016, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

Company Address

Eli Lilly and Co

Lilly Corporate Ctr, Drop Code 1
INDIANAPOLIS   IN   46285
P: +1317.2762000
F: +1317.2763492

Company Web Links